In this study, to determine the role of CD133 in colon cancer, we established a CD133knockout colon cancer cell line using CRISPR-Cas9 gene editing system and analyzed whether CD133 knockout contributed to attenuate the abilities of colon cancer cells, including colony formation, cell proliferation, migration, and invasion. The gene discussed is PROM1; the disease is malignant colon neoplasm.